Arresting Latinos for Marijuana in California: Possession Arrests in 33 Cities, 2006-08
A nationwide breakdown of pain management and prescription ... · "25 Legal Medical Marijuana...
Transcript of A nationwide breakdown of pain management and prescription ... · "25 Legal Medical Marijuana...
© 2019 athenahealth, Inc.
"Legality of cannabis by U.S. jurisdiction." Wikipedia, The Free Encyclopedia. www.wikipedia.com, 2019.
"25 Legal Medical Marijuana States and DC: Laws, Fees, and Possession Limits." ProCon.org: The Leading Source for Pros & Cons of Controversial Issues. www.ProCon.org, 2016.
"Medical Marijuana." The National Organization for the Reform of Marijuana Laws (NORML). www.NORML.org, 2016.
National Cannabis Industry Association, News & Resources, State Policy Map. https://thecannabisindustry.org, 2019.
"PDMP Data Collection Frequency." The Prescription Drug Monitoring Program Training and Technical Assistance Center, The Heller School for Social Policy and Management, Brandeis University. http://pdmpassist.org, 2019.
Sources include information found in NAMSDL documentation, Pew Charitable Trusts documentation, and individual state information found in (but not limited to) enacted state statutes, formally-issued state regulations, board of medicine/pharmacy guidelines, and consumer a�airs division documents.
"Overview of State Pain Management and Prescribing Policies." The National Alliance for Model State Drug Laws (NAMSDL). www.namsdl.org, 2019.
“Prescription Drug Physical Examination Requirements.” The Centers for Disease Control and Prevention (CDC). www.cdc.gov, 2019.
Additional sources include individual state information found in (but not limited to) enacted state statutes, formally-issued state regulations, and board of medicine/pharmacy guidelines, 2019
Sources include individual state information found in (but not limited to) enacted state statutes, formally-issued regulations, and board of medicine/pharmacy guidelines.
Independent research performed by Victor L Shopov, MBA, Healthcare Policy Consultant.
Research is current as of April 2019.
Please contact [email protected] with updates or information that may be relevant to this document. This document is intended for educational purposes only and does not constitute legal advice or opinion.
A nationwide breakdown of pain management and prescription regulationsState laws and policies around opioid prescriptions span a wide spectrum, from continuing medical education requirements to limits on how many pills physicians can prescribe. Explore the di�erent ways states are working to manage the opioid epidemic, and how the policies relate to prescribing patterns.
0% 5% 15%10%
2.3%
4%
4.7%
4.9%
5.1%
5.2%
5.9%
6.1%
6.2%
6.2%
6.3%
6.3%
6.5%
6.6%
6.6%
6.9%
7%
7.1%
7.3%
7.8%
8%
8%
8.1%
8.6%
9%
9%
9.1%
10.2%
12.5%
5.5%
8.5%
8.4%
*No client makes up more than 35% of visits or patients in the state; at least 6 clients per state; at least 20,000 visits between January and May, 2018. Source: athenaResearch
*No client makes up more than 35% of visits or patients in the state; at least 6 clients per state; at least 20,000 visits between January and May, 2018. Source: athenaResearch
How the regulations line up with opioid prescription rates, state by state
How state opioid prescribing rates compare, policy by policy
Legalized medical marijuana
*Recreational marijuana use legalized
34 / 51 (50 states + District of Columbia) 50 / 51 (50 states + District of Columbia)
33 / 51 (50 states + District of Columbia) 42 / 51 (50 states + District of Columbia)
36 / 51 (50 states + District of Columbia) 40 / 51 (50 states + District of Columbia)
Daily, 3 business days, weekly, County-level (daily)
3-7 days, 8-14 days, 30+ days
Frequency of updates to prescription drug monitoring programs
Continuing medical education required for clinicians who prescribe controlled substances
Substance abuse disorder assessment or evaluation required prior to opioid prescription
Regulations mandate or allow pharmacists to check ID before dispensing prescriptions
Day supply limits to written prescriptions for opioids and/or schedule II drugs unrelated to extenuating circumstances
How state-by-state laws and policies vary around prescription pain management
Percent of adult (18-64) commercial patients with an opioid prescription, January to May 2018*
ME*
NH
RICT
DE
MA*
VT*
MD
DC*
NJ
NY
SC
GA
VA
PA
NC
AL
WV
OH
MI*
TN
MS
KY
IN
IL
AR
LA
MO
IA
MN
KS
OK
TX FL
NE
SD
ND
NM
CO*
WY
MT
AZ
UT
NV*
ID
CA*
AK*HI
OR*
WA*
WI
ME
NH
RICT
DE
MA
VT
MD
DC
NJ
NY
SC
GA
VA
PA
NC
AL
WV
OH
MI
TN
MS
KY
IN
IL
AR
LA
MO
IA
MN
KS
OK
TX FL
NE
SD
ND
NM
CO
WY
MT
AZ
UT
NV
ID
CA
AKHI
OR
WA
WI
ME
NH
RICT
DE
MA
VT
MD
DC
NJ
NY
SC
GA
VA
PA
NC
AL
WV
OH
MI
TN
MS
KY
IN
IL
AR
LA
MO
IA
MN
KS
OK
TX FL
NE
SD
ND
NM
CO
WY
MT
AZ
UT
NV
ID
CA
AKHI
OR
WA
WI
NH
RICT
MD
DC
NJPAOH
TN
MS
AR
MO
IA
NE
SD
CO
MT
AK
ME
DE
MA
VT
NY
SC
GA
VA
NC
AL
WV
MI
KY
IN
IL
LA
MN
KS
OK
TX FL
ND
NM
WY
AZ
UT
NV
ID
CA
HI
OR
WA
WI
CT
MA
VT
DCSC
GA
NC
AL
WV
OH
MI
TN
MS
KY
IA
FL
NMAZ
UT
NV
CA
OR
ME
NH
RI
DEMD
NJ
NY
VA
PAIN
IL
AR
LA
MO
MN
KS
OK
TX
NE
SD
ND
CO
WY
MTID
AKHI
WA
WI
ME
NH
CT
DE
VT
DCSC
GA
VA
PA
NC
AL
WV
OH
MI
TN
KY
IN
LA
IA
OK
TX FL
NM
CO
WY
AZ
UT
NV
ID
CA
HI
WA
RI
MA
MD
NJ
NY
MS
IL
AR
MO
MN
KS
NE
SD
NDMT
AK
OR
WI
Percent of adult (18-64) commercial patients with an opioid prescription, January to May, 2018.*
0% 5% 15%
New Jersey
Connecticut
New York
New Hampshire
Massachusetts
Pennsylvania
Florida
Iowa
Texas
Ohio
Nevada
Illinois
West Virginia
Colorado
New Mexico
Washington
Louisiana
California
Mississippi
North Carolina
Wyoming
Michigan
Georgia
Kentucky
Utah
Nebraska
Alabama
Alaska
Tennessee
Idaho
Oregon
South Carolina
Missouri
Oklahoma
Arkansas
Arizona
Delaware
District of Columbia
Hawaii
Indiana
Kansas
Maine
Maryland
Minnesota
Montana
North Dakota
Rhode Island
South Dakota
Vermont
Virginia
Wisconsin
10%
N/A, insu�icient data
NJ
CT
NY
NH
MA
PA
FL
IA
TX
OH
NV
IL
WV
CO
NM
WA
LA
CA
MS
NC
WY
MI
GA
KY
UT
NE
AL
AK
TN
ID
OR
SC
MO
OK AR
Legalized medical marijuana
NJ
CT
NY
NH
MA
PA
FL
IA
TX
OH
NV
IL
WV
CO
NM
WA
LA
CA
MS
NC
WY
MI
GA
KY
UT
NE
AL
AK
TN
ID
OR
SC
MO
OK AR
NJ
CT
NY
NH
MA
PA
FL
IA
TX
OH
NV
IL
WV
CO
NM
WA
LA
CA
MS
NC
WY
MI
GA
KY
UT
NE
AL
AK
TN
ID
OR
SC
MO
OK AR
Substance abuse disorder assessment or evaluation required prior to opioid prescription
NJ
CT
NY
NH
MA
PA
FL
IA
TX
OH
NV
IL
WV
CO
NM
WA
LA
CA
MS
NC
WY
MI
GA
KY
UT
NE
AL
AK
TN
ID
OR
SC
MO
OK AR
Regulations mandate or allow pharmacists to check ID before dispensing prescriptions
NJ
CT
NY
NH
MA
PA
FL
IA
TX
OH
NV
IL
WV
CO
NM
WA
LA
CA
MS
NC
WY
MI
GA
KY
UT
NE
AL
AK
TN
ID
OR
SC
MO
OK AR
Continuing medical education required for clinicians who prescribe controlled substances
NJ
CT
NY
NH
MA
PA
FL
IA
TX
OH
NV
IL
WV
CO
NM
WA
LA
CA
MS
NC
WY
MI
GA
KY
UT
NE
AL
AK
TN
ID
OR
SC
MO
OK AR
Day supply limits to written prescriptions for opioids and/or schedule II drugs
3-7 days
18-14 days
30+ days
4.6%
9.2%
9.7%
Some restrictions apply
Legalized medical marijuana
Frequency of updates to prescription drug monitoring programs
Daily
3 business days
Weekly
County-level only (daily)
Day supply limits to written prescriptions for opioids and/or schedule II drugs
3-7 days
8-14 days
30+ days
Substance abuse disorder assessment required prior to opioid prescription
Regulations mandate or allow pharmacists to check ID before dispensing prescriptions
Some restrictions apply
Continuing medical education required for clinicians who prescribe controlled substances
Frequency of updates to prescription drug monitoring programs
Daily
3 business days
Weekly
County-level only (daily)
Some restrictions apply